Researchers Submit Patent Application, "Pharmaceutical Compositions Comprising Anti-Human Tslp Receptor Antibodies And Methods Of Using The Same", for Approval (USPTO 20240173405).

A patent application has been submitted by inventors Gearing, Guo, Li, Petaipimol, and Wang for pharmaceutical compositions containing antibodies that bind to the TSLP receptor (TSLP-R) and their use in treating diseases. The application describes different concentrations of the antibodies, buffers, excipients, surfactants, and amino acids. These compositions aim to inhibit TSLP and improve treatment for TSLP-related diseases. The application provides detailed information on the antibody's amino acid sequences and their potential medical applications. For more information, please refer to the full patent application. [Extracted from the article]